The global Ectoparasiticides market size was valued at US$ million in 2023. With growing demand in downstream market, the Ectoparasiticides is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Ectoparasiticides market. Ectoparasiticides are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Ectoparasiticides. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Ectoparasiticides market.
Anti-parasitic drugs mainly include: anti-malaria drugs, anti-amebiasis drugs and anti-trichomoniasis drugs, anti-leishmaniasis drugs, anti-fluke drugs and anti-filariasis drugs, intestinal anthelmintics, other parasitic drugs and other drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Ectoparasiticides market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Ectoparasiticides market. It may include historical data, market segmentation by Type (e.g., Permethrin, Sulfur), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Ectoparasiticides market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Ectoparasiticides market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Ectoparasiticides industry. This include advancements in Ectoparasiticides technology, Ectoparasiticides new entrants, Ectoparasiticides new investment, and other innovations that are shaping the future of Ectoparasiticides.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Ectoparasiticides market. It includes factors influencing customer ' purchasing decisions, preferences for Ectoparasiticides product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Ectoparasiticides market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Ectoparasiticides market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Ectoparasiticides market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Ectoparasiticides industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Ectoparasiticides market.
Market Segmentation:
Ectoparasiticides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Permethrin
Sulfur
Lindane
Benzyl Benzoate
Ivermectin
Others
Segmentation by application
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis
Sanofi
Virbac
Vetoquinol
Dechra Pharmaceuticals
Advance Properties OOD/Huvepharma
Heranba
Tagros
Meghmani
Crop Life Science Limited
Aestar
Gharda
Guangdong Liwei
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ectoparasiticides Market Size 2019-2030
2.1.2 Ectoparasiticides Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Ectoparasiticides Segment by Type
2.2.1 Permethrin
2.2.2 Sulfur
2.2.3 Lindane
2.2.4 Benzyl Benzoate
2.2.5 Ivermectin
2.2.6 Others
2.3 Ectoparasiticides Market Size by Type
2.3.1 Ectoparasiticides Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Ectoparasiticides Market Size Market Share by Type (2019-2024)
2.4 Ectoparasiticides Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Cattle
2.4.4 Pigs
2.4.5 Sheep and Goats
2.4.6 Poultry
2.4.7 Others
2.5 Ectoparasiticides Market Size by Application
2.5.1 Ectoparasiticides Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Ectoparasiticides Market Size Market Share by Application (2019-2024)
3 Ectoparasiticides Market Size by Player
3.1 Ectoparasiticides Market Size Market Share by Players
3.1.1 Global Ectoparasiticides Revenue by Players (2019-2024)
3.1.2 Global Ectoparasiticides Revenue Market Share by Players (2019-2024)
3.2 Global Ectoparasiticides Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Ectoparasiticides by Regions
4.1 Ectoparasiticides Market Size by Regions (2019-2024)
4.2 Americas Ectoparasiticides Market Size Growth (2019-2024)
4.3 APAC Ectoparasiticides Market Size Growth (2019-2024)
4.4 Europe Ectoparasiticides Market Size Growth (2019-2024)
4.5 Middle East & Africa Ectoparasiticides Market Size Growth (2019-2024)
5 Americas
5.1 Americas Ectoparasiticides Market Size by Country (2019-2024)
5.2 Americas Ectoparasiticides Market Size by Type (2019-2024)
5.3 Americas Ectoparasiticides Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ectoparasiticides Market Size by Region (2019-2024)
6.2 APAC Ectoparasiticides Market Size by Type (2019-2024)
6.3 APAC Ectoparasiticides Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Ectoparasiticides by Country (2019-2024)
7.2 Europe Ectoparasiticides Market Size by Type (2019-2024)
7.3 Europe Ectoparasiticides Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ectoparasiticides by Region (2019-2024)
8.2 Middle East & Africa Ectoparasiticides Market Size by Type (2019-2024)
8.3 Middle East & Africa Ectoparasiticides Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Ectoparasiticides Market Forecast
10.1 Global Ectoparasiticides Forecast by Regions (2025-2030)
10.1.1 Global Ectoparasiticides Forecast by Regions (2025-2030)
10.1.2 Americas Ectoparasiticides Forecast
10.1.3 APAC Ectoparasiticides Forecast
10.1.4 Europe Ectoparasiticides Forecast
10.1.5 Middle East & Africa Ectoparasiticides Forecast
10.2 Americas Ectoparasiticides Forecast by Country (2025-2030)
10.2.1 United States Ectoparasiticides Market Forecast
10.2.2 Canada Ectoparasiticides Market Forecast
10.2.3 Mexico Ectoparasiticides Market Forecast
10.2.4 Brazil Ectoparasiticides Market Forecast
10.3 APAC Ectoparasiticides Forecast by Region (2025-2030)
10.3.1 China Ectoparasiticides Market Forecast
10.3.2 Japan Ectoparasiticides Market Forecast
10.3.3 Korea Ectoparasiticides Market Forecast
10.3.4 Southeast Asia Ectoparasiticides Market Forecast
10.3.5 India Ectoparasiticides Market Forecast
10.3.6 Australia Ectoparasiticides Market Forecast
10.4 Europe Ectoparasiticides Forecast by Country (2025-2030)
10.4.1 Germany Ectoparasiticides Market Forecast
10.4.2 France Ectoparasiticides Market Forecast
10.4.3 UK Ectoparasiticides Market Forecast
10.4.4 Italy Ectoparasiticides Market Forecast
10.4.5 Russia Ectoparasiticides Market Forecast
10.5 Middle East & Africa Ectoparasiticides Forecast by Region (2025-2030)
10.5.1 Egypt Ectoparasiticides Market Forecast
10.5.2 South Africa Ectoparasiticides Market Forecast
10.5.3 Israel Ectoparasiticides Market Forecast
10.5.4 Turkey Ectoparasiticides Market Forecast
10.5.5 GCC Countries Ectoparasiticides Market Forecast
10.6 Global Ectoparasiticides Forecast by Type (2025-2030)
10.7 Global Ectoparasiticides Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Ectoparasiticides Product Offered
11.1.3 Bayer Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 MSD Animal Health
11.2.1 MSD Animal Health Company Information
11.2.2 MSD Animal Health Ectoparasiticides Product Offered
11.2.3 MSD Animal Health Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 MSD Animal Health Main Business Overview
11.2.5 MSD Animal Health Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Ectoparasiticides Product Offered
11.3.3 Boehringer Ingelheim Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Ceva Sante Animale
11.4.1 Ceva Sante Animale Company Information
11.4.2 Ceva Sante Animale Ectoparasiticides Product Offered
11.4.3 Ceva Sante Animale Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ceva Sante Animale Main Business Overview
11.4.5 Ceva Sante Animale Latest Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Information
11.5.2 Eli Lilly and Company Ectoparasiticides Product Offered
11.5.3 Eli Lilly and Company Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly and Company Main Business Overview
11.5.5 Eli Lilly and Company Latest Developments
11.6 Zoetis
11.6.1 Zoetis Company Information
11.6.2 Zoetis Ectoparasiticides Product Offered
11.6.3 Zoetis Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Zoetis Main Business Overview
11.6.5 Zoetis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Ectoparasiticides Product Offered
11.7.3 Sanofi Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Virbac
11.8.1 Virbac Company Information
11.8.2 Virbac Ectoparasiticides Product Offered
11.8.3 Virbac Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Virbac Main Business Overview
11.8.5 Virbac Latest Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Company Information
11.9.2 Vetoquinol Ectoparasiticides Product Offered
11.9.3 Vetoquinol Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Vetoquinol Main Business Overview
11.9.5 Vetoquinol Latest Developments
11.10 Dechra Pharmaceuticals
11.10.1 Dechra Pharmaceuticals Company Information
11.10.2 Dechra Pharmaceuticals Ectoparasiticides Product Offered
11.10.3 Dechra Pharmaceuticals Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Dechra Pharmaceuticals Main Business Overview
11.10.5 Dechra Pharmaceuticals Latest Developments
11.11 Advance Properties OOD/Huvepharma
11.11.1 Advance Properties OOD/Huvepharma Company Information
11.11.2 Advance Properties OOD/Huvepharma Ectoparasiticides Product Offered
11.11.3 Advance Properties OOD/Huvepharma Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Advance Properties OOD/Huvepharma Main Business Overview
11.11.5 Advance Properties OOD/Huvepharma Latest Developments
11.12 Heranba
11.12.1 Heranba Company Information
11.12.2 Heranba Ectoparasiticides Product Offered
11.12.3 Heranba Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Heranba Main Business Overview
11.12.5 Heranba Latest Developments
11.13 Tagros
11.13.1 Tagros Company Information
11.13.2 Tagros Ectoparasiticides Product Offered
11.13.3 Tagros Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Tagros Main Business Overview
11.13.5 Tagros Latest Developments
11.14 Meghmani
11.14.1 Meghmani Company Information
11.14.2 Meghmani Ectoparasiticides Product Offered
11.14.3 Meghmani Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Meghmani Main Business Overview
11.14.5 Meghmani Latest Developments
11.15 Crop Life Science Limited
11.15.1 Crop Life Science Limited Company Information
11.15.2 Crop Life Science Limited Ectoparasiticides Product Offered
11.15.3 Crop Life Science Limited Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Crop Life Science Limited Main Business Overview
11.15.5 Crop Life Science Limited Latest Developments
11.16 Aestar
11.16.1 Aestar Company Information
11.16.2 Aestar Ectoparasiticides Product Offered
11.16.3 Aestar Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Aestar Main Business Overview
11.16.5 Aestar Latest Developments
11.17 Gharda
11.17.1 Gharda Company Information
11.17.2 Gharda Ectoparasiticides Product Offered
11.17.3 Gharda Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Gharda Main Business Overview
11.17.5 Gharda Latest Developments
11.18 Guangdong Liwei
11.18.1 Guangdong Liwei Company Information
11.18.2 Guangdong Liwei Ectoparasiticides Product Offered
11.18.3 Guangdong Liwei Ectoparasiticides Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Guangdong Liwei Main Business Overview
11.18.5 Guangdong Liwei Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
